Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

@article{Sever2005ReductionIC,
  title={Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).},
  author={Peter S Sever and Neil R. Poulter and Bj{\"o}rn Dahl{\"o}f and Hans Wedel and Rory Collins and Gareth D Beevers and Mark J. Caulfield and Sverre Erik Kjeldsen and Arni Kristinsson and Gordon T. McInnes and Jesper Mehlsen and Markku S Nieminen and Eoin O'brien and Jan B Ostergren},
  journal={Diabetes care},
  year={2005},
  volume={28 5},
  pages={1151-7}
}
OBJECTIVE This study aims to establish the benefits of lowering cholesterol in diabetic patients with well-controlled hypertension and average/below-average cholesterol concentrations, but without established coronary disease. RESEARCH DESIGN AND METHODS In the lipid-lowering arm of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT-LLA), 10,305 hypertensive patients with no history of coronary heart disease (CHD) but at least three cardiovascular risk factors were randomly assigned to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 93 extracted citations

Lipids and lipid management in diabetes.

Best practice & research. Clinical endocrinology & metabolism • 2014
View 4 Excerpts
Highly Influenced

Diabetic cardiomyopathy and anesthesia: bench to bedside.

Anesthesiology • 2008
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Primary prevention of Table 4—HR for end points included in total cardiovascular events and procedures (diabetic patients

HM Colhoun, DJ Betteridge, +7 authors JH Fuller
DIABETES CARE, VOLUME 28, • 2005
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…